5 completed, 2 recruiting, 1 active not recruiting. 7 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Recruiting 2, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow HTA Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection [18F]Fluorbetazine injection - Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD) | Phase 3 | Recruiting | HTA Co., Ltd. | 400 | 2025-06-20 | 2026-08-14 |
| Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer Florastamin[18F] Injection - Prostate Cancer | Phase 3 | Completed | HTA Co., Ltd. | 131 | 2024-12-19 | 2026-09-25 |
| Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs 68Ga-DOTATATE Injection - NETs | Phase 3 | Active not recruiting | HTA Co., Ltd. | 95 | 2024-01-08 | 2025-08-13 |
| Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer Technetium Tc 99m Sulfur Colloid Injection, Mitoxantrone Hydrochloride Injection for Tracing - Sentinel Nodes, Breast Cancer | Phase 3 | Completed | HTA Co., Ltd. | 213 | 2024-01-02 | 2026-08-14 |
| A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs 177Lu-DOTATATE injection, Octreotide LAR (Long-acting release) - NETS Ga68 Lu177 | Phase 3 | Recruiting | HTA Co., Ltd. | 184 | 2023-12-12 | 2025-07-10 |
| A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection [18F]Florbetazine - MCI, AD | Phase 1 | Completed | HTA Co., Ltd. | 28 | 2023-11-06 | 2025-07-10 |
| Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer [18F]Florastamin Injection - Prostate Cancer | Phase 3 | Completed | HTA Co., Ltd. | 287 | 2023-10-20 | 2026-09-29 |
| Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT Sodium Fluoride F-18 Injection, Technetium[99mTc] Methylenediphosphonate Injection - Bone Metastases | Phase 3 | Completed | HTA Co., Ltd. | 280 | 2021-03-29 | 2022-11-14 |
Prostatic Neoplasms (3) · Breast Neoplasms (2) · Cognitive Dysfunction (1) · Lung Neoplasms (1)
Injections (1) · Mitoxantrone (1) · Technetium Tc 99m Medronate (1) · Technetium Tc 99m Sulfur Colloid (1) · gallium Ga 68 dotatate (1) · lutetium Lu 177 dotatate (1)
China (8)
Zaoqing Fan, MD (1) · Zhi Yang, MD (1)